Evidence map›Paper›PMID 40241086›Full record

ArticleBMC medicine2025

Correction: Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer.

Shuichi Mitsunaga, Masafumi Ikeda, Makoto Ueno, Satoshi Kobayashi, Masahiro Tsuda, Ikuya Miki, Takamichi Kuwahara, Kazuo Hara, Yukiko Takayama, Yutaro Matsunaga and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Shuichi MitsunagaDivision of Biomarker Discovery, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. smitsuna@east.ncc.go.jp.
Masafumi IkedaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Makoto UenoDepartment of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Satoshi KobayashiDepartment of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Masahiro TsudaDepartment of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
Ikuya MikiDepartment of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
Takamichi KuwaharaDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Kazuo HaraDepartment of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yukiko TakayamaDepartment of Internal Medicine, Institute of Gastroenterology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Yutaro MatsunagaDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Keiji HanadaDepartment of Gastroenterology, Onomichi General Hospital, Onomichi, Hiroshima, Japan.
Akinori ShimizuDepartment of Gastroenterology, Onomichi General Hospital, Onomichi, Hiroshima, Japan.
Hitoshi YoshidaDepartment of Medicine, Division of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
Tomohiro NomotoDepartment of Medicine, Division of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
Kenji TakahashiDepartment of Medicine, Division of Gastroenterology, Asahikawa Medical University, Asahikawa, Japan.
Hidetaka IwamotoDepartment of Medicine, Division of Gastroenterology, Asahikawa Medical University, Asahikawa, Japan.
Hideaki IwamaDepartment of Gastroenterological Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Etsuro HatanoDepartment of Gastroenterological Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Kohei NakataDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masafumi NakamuraDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hiroko SudoToray Industries, Inc, Kamakura, Japan.
Satoko TakizawaToray Industries, Inc, Kamakura, Japan.
Atsushi OchiaiResearch Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40241086
PMCPMC12004790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.